Imidobenzyle en es it fr

Imidobenzyle Brand names, Imidobenzyle Analogs

Imidobenzyle Brand Names Mixture

  • No information avaliable

Imidobenzyle Chemical_Formula


Imidobenzyle RX_link

Imidobenzyle fda sheet

Imidobenzyle FDA

Imidobenzyle msds (material safety sheet)

Imidobenzyle Synthesis Reference

No information avaliable

Imidobenzyle Molecular Weight

280.407 g/mol

Imidobenzyle Melting Point

174.5 oC

Imidobenzyle H2O Solubility

18.2 mg/L

Imidobenzyle State


Imidobenzyle LogP


Imidobenzyle Dosage Forms


Imidobenzyle Indication

For the relief of symptoms of depression and as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older.

Imidobenzyle Pharmacology

Imipramine is a tricyclic antidepressant with general pharmacological properties similar to those of structurally related tricyclic antidepressant drugs such as amitriptyline and doxepin. A tertiary amine, imipramine inhibits the reuptake of serotonin more so than most secondary amine tricyclics, meaning that it blocks the reuptake of neurotransmitters serotonin and noradrenaline almost equally. It is also effective in migraine prophylaxis, but not in abortion of acute migraine attack.

Imidobenzyle Absorption

Rapidly and well absorbed after oral administration

Imidobenzyle side effects and Toxicity

Oral, rat LD50: 355 to 682 mg/kg. Toxic signs proceed progressively from depression, irregular respiration and ataxia to convulsions and death.

Imidobenzyle Patient Information

Imidobenzyle Organisms Affected

Humans and other mammals